Sheri M Krams1, Olivia M Martinez. 1. Department of Surgery, Division of Transplantation, Stanford University School of Medicine, Stanford, California 94305-5492, USA.
Abstract
PURPOSE OF REVIEW: To summarize recent advances that contribute to our understanding of the pathobiology of Epstein-Barr virus (EBV)-associated posttransplant lymphoproliferative disease (PTLD), the host immune response to virally infected B cells, and the molecular basis for the effects of mammalian target of rapamycin inhibitors on EBV+ B-cell lymphomas. RECENT FINDINGS: Cytogenetic and genomic analyses support the concept that the underlying biology of EBV-associated PTLD is complex. Transplant recipients can generate and maintain significant populations of EBV-specific CD8+ memory T cells but the function of these cells may be impaired. EBV invokes multiple strategies to subvert and evade the host immune response. The phosphoinositide-3 kinase/Akt/mammalian target of rapamycin signal transduction pathway is a nexus for growth and survival signals in PTLD-associated EBV+ B-cell lymphomas. SUMMARY: Multiple factors influence the development of EBV-associated PTLD including the host immune response to EBV, virally induced effects on the infected cell and the host immune system, and the type and intensity of immunosuppression.
PURPOSE OF REVIEW: To summarize recent advances that contribute to our understanding of the pathobiology of Epstein-Barr virus (EBV)-associated posttransplant lymphoproliferative disease (PTLD), the host immune response to virally infected B cells, and the molecular basis for the effects of mammalian target of rapamycin inhibitors on EBV+ B-cell lymphomas. RECENT FINDINGS: Cytogenetic and genomic analyses support the concept that the underlying biology of EBV-associated PTLD is complex. Transplant recipients can generate and maintain significant populations of EBV-specific CD8+ memory T cells but the function of these cells may be impaired. EBV invokes multiple strategies to subvert and evade the host immune response. The phosphoinositide-3 kinase/Akt/mammalian target of rapamycin signal transduction pathway is a nexus for growth and survival signals in PTLD-associated EBV+ B-cell lymphomas. SUMMARY: Multiple factors influence the development of EBV-associated PTLD including the host immune response to EBV, virally induced effects on the infected cell and the host immune system, and the type and intensity of immunosuppression.
Authors: Amy E Guppy; Eira Rawlings; J Alejandro Madrigal; Peter L Amlot; Linda D Barber Journal: Transplantation Date: 2007-12-15 Impact factor: 4.939
Authors: R A McDonald; J M Smith; M Ho; R Lindblad; D Ikle; P Grimm; R Wyatt; M Arar; D Liereman; N Bridges; W Harmon Journal: Am J Transplant Date: 2008-05 Impact factor: 8.086
Authors: Tianli Xia; Andrea O'Hara; Iguaracyra Araujo; Jose Barreto; Eny Carvalho; Jose Bahia Sapucaia; Juan Carlos Ramos; Estela Luz; Celia Pedroso; Michele Manrique; Ngoc L Toomey; Carlos Brites; Dirk P Dittmer; William J Harrington Journal: Cancer Res Date: 2008-03-01 Impact factor: 12.701
Authors: A D Kirk; W S Cherikh; M Ring; G Burke; D Kaufman; S J Knechtle; S Potdar; R Shapiro; V R Dharnidharka; H M Kauffman Journal: Am J Transplant Date: 2007-09-14 Impact factor: 8.086
Authors: Stephan Sauer; Ludovica Bruno; Arnulf Hertweck; David Finlay; Marion Leleu; Mikhail Spivakov; Zachary A Knight; Bradley S Cobb; Doreen Cantrell; Eric O'Connor; Kevan M Shokat; Amanda G Fisher; Matthias Merkenschlager Journal: Proc Natl Acad Sci U S A Date: 2008-05-28 Impact factor: 11.205
Authors: C Cutler; K Stevenson; H T Kim; J Brown; S McDonough; M Herrera; C Reynolds; D Liney; G Kao; V Ho; P Armand; J Koreth; E Alyea; B R Dey; E Attar; T Spitzer; V A Boussiotis; J Ritz; R Soiffer; J H Antin; K Ballen Journal: Bone Marrow Transplant Date: 2010-08-09 Impact factor: 5.483